z-logo
open-access-imgOpen Access
Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors
Author(s) -
Kohei Fujita,
Yuki Yamamoto,
Osamu Kanai,
Misato Okamura,
Koichi Nakatani,
Tadashi Mio
Publication year - 2020
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofaa067
Subject(s) - medicine , lung cancer , immunotherapy , immune system , tuberculosis , mycobacterium tuberculosis , immunology , mycobacterium avium complex , disease , lung , pathology
Immunotherapy with immune checkpoint inhibitors (ICIs), while ameliorating lung cancer, can cause infectious diseases, including tuberculosis, in addition to immune-related noninfectious complications. In the clinical setting, the efficacy of ICIs to treat mycobacterial infection remains controversial. We report 3 cases of acute Mycobacterium avium complex lung disease during immunotherapy with ICIs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here